Trial: 202002113

A Phase II Study of Cabozantinib and Temozolomide in Patients with Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas

Phase

II

Principal Investigator

Weiss, Mia

Disease Site

Soft Tissue

Learn more about this study at: clinicaltrials.gov